Characteristics Associated with Nodal and Distant Recurrence After Radical Esophagectomy for Squamous Cell Carcinoma of the Thoracic Esophagus

被引:12
作者
Kanda, Mitsuro [1 ]
Koike, Masahiko [1 ]
Shimizu, Dai [1 ]
Tanaka, Chie [1 ]
Hattori, Norifumi [1 ]
Hayashi, Masamichi [1 ]
Yamada, Suguru [1 ]
Omae, Kenji [2 ]
Kodera, Yasuhiro [1 ]
机构
[1] Nagoya Univ, Dept Gastroenterol Surg Surg 2, Grad Sch Med, Nagoya, Aichi, Japan
[2] Fukushima Med Univ Hosp, Dept Innovat Res & Educ Clinicians & Trainees DiR, Fukushima, Japan
关键词
PROGNOSTIC-FACTORS; RISK-FACTORS; CANCER; SURGERY; PATTERN; DISSECTION; CHEMORADIOTHERAPY; RESECTION; OUTCOMES; TERM;
D O I
10.1245/s10434-020-08433-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Recurrence after radical resection of esophageal squamous cell carcinoma (ESCC) is common. Limited evidence is available about the differences in clinical characteristics, risk factors, and prognostic significance between nodal and distant recurrence of thoracic ESCC. Patients and Methods We retrospectively analyzed 341 patients who underwent radical resection of thoracic ESCC and experienced (1) initial recurrence only in lymph nodes (n = 39), (2) recurrence only at distant organs (n = 57), or (3) no recurrences (n = 245) after follow-up >= 24 months. Clinicopathological characteristics, survival times, and risk factors were compared between the nodal and distant recurrence groups. Results The median follow-up time was 57.8 months. Metastasectomy as initial treatment for the recurrence was performed for six (15.4%) patients in the nodal recurrence group and one patient in the distant recurrence group. Compared with the nodal recurrence group, patients with distant recurrence had significantly shorter disease-free survival [hazard ratio (HR) 1.68, 95% confidence interval (CI) 1.10-2.57, P = 0.0169], postrecurrence survival (HR 1.77, 95% CI 1.01-3.10, P = 0.0476), and overall survival (HR 1.98, 95% CI 1.12-3.51, P = 0.0193). The distant recurrence group had significantly larger macroscopic tumor size and more advanced pathological T stage than the nodal recurrence group, whereas preoperative treatment, tumor location, number of fields dissected, tumor differentiation, lymphatic involvement, and vessel invasion were not significantly different between the two groups. Conclusions Survival times and recurrence risk factors differed between patients with nodal and distant recurrence after radical resection of thoracic ESCC.
引用
收藏
页码:3195 / 3205
页数:11
相关论文
共 40 条
[31]   Different Recurrence Pattern After Neoadjuvant Chemoradiotherapy Compared to Surgery Alone in Esophageal Cancer Patients [J].
Smit, Justin K. ;
Guler, Sahin ;
Beukema, Jannet C. ;
Mul, Veronique E. ;
Burgerhof, Johannes G. M. ;
Hospers, Geke A. P. ;
Plukker, John Th. M. .
ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (12) :4008-4015
[32]   Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Stahl, M. ;
Mariette, C. ;
Haustermans, K. ;
Cervantes, A. ;
Arnold, D. .
ANNALS OF ONCOLOGY, 2013, 24 :51-56
[33]   Prognostic factors in patients with recurrence after complete resection of esophageal squamous cell carcinoma [J].
Su, Xiao-Dong ;
Zhang, Dong-Kun ;
Zhang, Xu ;
Lin, Peng ;
Long, Hao ;
Rong, Tie-Hua .
JOURNAL OF THORACIC DISEASE, 2014, 6 (07) :949-957
[34]  
van Laarhoven HWM, 2017, LANCET ONCOL, V18, pE639, DOI 10.1016/S1470-2045(17)30812-4
[35]   Recurrence pattern of squamous cell carcinoma in the midthoracic esophagus: implications for the clinical target volume design of postoperative radiotherapy [J].
Wang, Xiaoli ;
Luo, Yijun ;
Li, Minghuan ;
Yan, Hongjiang ;
Sun, Mingping ;
Fan, Tingyong .
ONCOTARGETS AND THERAPY, 2016, 9 :6021-6027
[36]   A retrospective study of pattern of recurrence after radical surgery for thoracic esophageal carcinoma with or without postoperative radiotherapy [J].
Wang, Yichun ;
Zhang, Li ;
Ye, Dongmei ;
Xia, Wanli ;
Jiang, Jun ;
Wang, Xiumei ;
Zhang, Mingxia ;
Wang, Fan .
ONCOLOGY LETTERS, 2018, 15 (03) :4033-4039
[37]   Multi-institutional Analysis of Recurrence and Survival After Neoadjuvant Chemoradiotherapy of Esophageal Cancer Impact of Histology on Recurrence Patterns and Outcomes [J].
Xi, Mian ;
Yang, Yadi ;
Zhang, Li ;
Yang, Hong ;
Merrell, Kenneth W. ;
Hallemeier, Christopher L. ;
Shen, Robert K. ;
Haddock, Michael G. ;
Hofstetter, Wayne L. ;
Maru, Dipen M. ;
Ho, Linus ;
Wu, Carol C. ;
Liu, Mengzhong ;
Lin, Steven H. .
ANNALS OF SURGERY, 2019, 269 (04) :663-670
[38]   Patterns and Outcomes of Recurrent Esophageal Cancer After Curative Esophagectomy [J].
Yamashita, Kotaro ;
Watanabe, Masayuki ;
Mine, Shinji ;
Kurogochi, Takanori ;
Okamura, Akihiko ;
Hayami, Masaru ;
Imamura, Yu .
WORLD JOURNAL OF SURGERY, 2017, 41 (09) :2337-2344
[39]   Comparison of the 7th and proposed 8th editions of the AJCC/UICC TNM staging system for esophageal squamous cell carcinoma underwent radical surgery [J].
Zhang, D. ;
Zheng, Y. ;
Wang, Z. ;
Huang, Q. ;
Cao, X. ;
Wang, F. ;
Liu, S. .
EJSO, 2017, 43 (10) :1949-1955
[40]   Recurrence Risk Based on Pathologic Stage After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Implications for Risk-Based Postoperative Surveillance Strategies [J].
Zhou, Sha ;
Liu, Shiliang ;
Zhang, Li ;
Guo, Suping ;
Shen, Jingxian ;
Li, Qiaoqiao ;
Yang, Hong ;
Feng, Yanfen ;
Liu, Mengzhong ;
Lin, Steven H. ;
Xi, Mian .
ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (12) :3639-3646